Tag: Pancreatic neuroendocrine tumors

Home / Pancreatic neuroendocrine tumors

Categories

Belzutifan has been approved by the FDA for malignancies linked to von Hippel-Lindau disease

August 2021: Belzutifan (Welireg, Merck), a hypoxia-inducible factor inhibitor, has been approved by the Food and Drug Administration for adult patients with von Hippel-Lindau disease who require ther...
pancreatic-neuroendocrine-tumors

Scan the code